Vincent Liu

Vincent Liu is currently a Consultant at Genesis Therapeutics, specializing in AI small molecule drug discovery and supporting external pharma partner/investor discussions. Prior to this role, Vincent worked as a Graduate Researcher at Stanford University School of Medicine, focusing on thesis research in innate immune cells in human cancers. Vincent has a strong background in computational biology and machine learning, with experience at various institutions such as Cartography Biosciences, Memorial Sloan Kettering Cancer Center, and Columbia University. Their interdisciplinary approach to biology began as a Research Intern at City of Hope, and they continue to contribute to the field through teaching and research.